According to a report by MedMarket Diligence, investments and other financings into the medical technology market have topped $400 million during both July and August. September is expected to bring another month with more than $400 million in investments.

Wireless sensing and communications developer CardioMEMS was one medtech company that scooped up funding last month: the company announced a $22.1 million round of financing. The additional funds will bankroll its heart failure clinical trial, which was initiated in September of 2007 and is currently taking place in more than 65 heart centers across the U.S.

Here's a graph from MedMarket Diligence that chronicles overall investments in medical technology companies during the past six months:

Source: MedMarket Diligence LLC

For more, read this article from Advanced Medical Technologies